ImmuCell
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $5,472 | $7,257 | $5,096 | $5,396 |
Gross Profit | 1,230 | 2,295 | 1,258 | 1,266 |
EBITDA | -715 | 367 | -318 | -1,184 |
EBIT | -1,386 | -300 | -1,003 | -1,884 |
Net Income | -1,531 | -437 | -1,140 | -940 |
Net Change In Cash | 5,472 | 7,257 | 5,096 | 5,396 |
Free Cash Flow | 471 | 348 | -928 | |
Cash | 1,324 | 960 | 979 | 1,989 |
Basic Shares | 7,810 | 7,750 | 7,750 | 7,746 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $17,471 | $18,568 | $19,243 | $15,342 |
Gross Profit | 4,396 | 7,649 | 8,656 | 6,863 |
EBITDA | -2,504 | 188 | 257 | 967 |
EBIT | -5,221 | -2,299 | -2,214 | -1,380 |
Net Income | -5,774 | -2,494 | -78 | -1,022 |
Net Change In Cash | 17,471 | 18,568 | 19,243 | 15,342 |
Cost of Revenue | 656 | |||
Free Cash Flow | -6,566 | -5,519 | -1,654 | -2,756 |
Cash | 978 | 5,792 | 10,185 | 7,946 |
Basic Shares | 7,747 | 7,745 | 7,592 | 7,213 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.19 |
2024-03-31 | -$0.05 |
2023-12-31 | -$0.14 |
2023-09-30 | -$0.12 |
